BR112017022045A2 - composição e kits para matrizes de microgel pseudoplástico - Google Patents

composição e kits para matrizes de microgel pseudoplástico

Info

Publication number
BR112017022045A2
BR112017022045A2 BR112017022045A BR112017022045A BR112017022045A2 BR 112017022045 A2 BR112017022045 A2 BR 112017022045A2 BR 112017022045 A BR112017022045 A BR 112017022045A BR 112017022045 A BR112017022045 A BR 112017022045A BR 112017022045 A2 BR112017022045 A2 BR 112017022045A2
Authority
BR
Brazil
Prior art keywords
microgel
pseudoplastic
kits
arrays
composition
Prior art date
Application number
BR112017022045A
Other languages
English (en)
Other versions
BR112017022045B1 (pt
Inventor
Beal Salamone Ann
CHUNG Eunna
Charles Salamone Joseph
Elizabeth Reilly Katelyn
Xiaoyu-Chen Leung Kelly
Jean Suggs Laura
Original Assignee
Rochal Ind Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rochal Ind Llc filed Critical Rochal Ind Llc
Publication of BR112017022045A2 publication Critical patent/BR112017022045A2/pt
Publication of BR112017022045B1 publication Critical patent/BR112017022045B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/225—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/26—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/362—Skin, e.g. dermal papillae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3625—Vascular tissue, e.g. heart valves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3633—Extracellular matrix [ECM]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/12—Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Hematology (AREA)
  • Dispersion Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Polymers & Plastics (AREA)
  • Peptides Or Proteins (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)

Abstract

essa invenção se refere, de modo geral, as partículas de microgel peguiladas, reticuladas, deformáveis e intumescíveis em água porém insolúveis em água e as macromoléculas com base em proteína que são pseudoplásticas (desbaste de cisalhamento) e fluem no meio aquoso sob cisalhamento e que podem ser injetadas ou tornadas fluidas, em que as partículas de microgel podem ser reformadas em um grupo de partículas de microgel quando o cisalhamento é removido. as partículas de microgel funcionam como uma matriz para sustentar o crescimento da célula, viabilidade e proliferação.
BR112017022045-8A 2015-04-17 2016-04-12 Composição para matrizes de microgel pseudoplástico BR112017022045B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14/689,625 US20160303281A1 (en) 2015-04-17 2015-04-17 Composition and kits for pseudoplastic microgel matrices
US14/689,625 2015-04-17
PCT/US2016/027131 WO2016168196A1 (en) 2015-04-17 2016-04-12 Composition and kits for pseudoplastic microgel matrices

Publications (2)

Publication Number Publication Date
BR112017022045A2 true BR112017022045A2 (pt) 2018-07-03
BR112017022045B1 BR112017022045B1 (pt) 2023-11-28

Family

ID=57126813

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017022045-8A BR112017022045B1 (pt) 2015-04-17 2016-04-12 Composição para matrizes de microgel pseudoplástico

Country Status (14)

Country Link
US (2) US20160303281A1 (pt)
EP (1) EP3283057B1 (pt)
JP (1) JP6930733B2 (pt)
KR (1) KR102592242B1 (pt)
CN (1) CN107708675B (pt)
AU (1) AU2016250012B2 (pt)
BR (1) BR112017022045B1 (pt)
CA (1) CA2982352A1 (pt)
DK (1) DK3283057T3 (pt)
ES (1) ES2895947T3 (pt)
HK (1) HK1245663A1 (pt)
MX (1) MX2017013002A (pt)
PT (1) PT3283057T (pt)
WO (1) WO2016168196A1 (pt)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL282559B (en) 2014-07-17 2022-07-01 Univ California Self-reinforced and controllable microgel particles for biomedical applications
WO2017142879A1 (en) 2016-02-16 2017-08-24 The Regents Of The University Of California Methods for immune system modulation with microporous annealed particle gels
EP3562523A4 (en) * 2016-12-29 2020-09-30 Tempo Therapeutics, Inc. PROCESSES AND SYSTEMS FOR THE TREATMENT OF A MEDICAL IMPLANT SITE
IT201700087978A1 (it) * 2017-07-31 2019-01-31 Univ Degli Studi Genova Scaffold di idrogel tridimensionale per colture cellulari e metodo per la sua produzione
KR102172222B1 (ko) * 2017-12-29 2020-10-30 서울대학교산학협력단 단백질 약물 전달용 광가교 마이크로젤 및 그의 제조 방법
CN111886031B (zh) * 2018-01-10 2022-10-14 G2G生物公司 含胶原蛋白肽的聚己内酯微球填充物及其制备方法
US20190240335A1 (en) * 2018-02-07 2019-08-08 Promedon S.A. Biocompatible Hydrogel Compositions
CN110193094A (zh) * 2018-02-24 2019-09-03 上海优先生物医学工程有限公司 一种软组织填充修复材料及其制备方法和用途
US10335421B1 (en) 2018-02-26 2019-07-02 Aisha Chaudhry Topical wound care formulation
KR102090576B1 (ko) * 2018-02-26 2020-03-18 주식회사 엔도비전 상처치료용 다층 드레싱재
CN108653196A (zh) * 2018-04-11 2018-10-16 燕山大学 一种脂质体复合双响应载药水凝胶的制备方法
CN110402918A (zh) * 2018-04-27 2019-11-05 庄明华 一种保存骨组织材料的方法
US20210402061A1 (en) 2018-05-09 2021-12-30 The Johns Hopkins University Nanofiber-hydrogel composites for cell and tissue delivery
CN108715833B (zh) * 2018-06-01 2021-09-14 天晴干细胞股份有限公司 一种负载血小板裂解液的微球制备方法
GB201810925D0 (en) * 2018-07-03 2018-08-15 Blueberry Therapeutics Ltd Compositions and methods of treatment
CN109224123B (zh) * 2018-10-11 2021-04-09 成都迪康中科生物医学材料有限公司 具有抑制肿瘤作用的纳米羟基磷灰石复合材料及制备方法
CN109298180A (zh) * 2018-11-19 2019-02-01 中南大学 一种检测鼠伤寒沙门氏菌的方法
GB201820021D0 (en) * 2018-12-07 2019-01-23 Univ Birmingham Ocular hydrogel compositions
GB201820018D0 (en) * 2018-12-07 2019-01-23 Univ Birmingham Therapeutic hydrogel compositions
CN109481739B (zh) * 2018-12-12 2021-07-30 四川大学华西医院 一种骨关节润滑剂及其制备方法
US11832879B2 (en) * 2019-03-08 2023-12-05 Neuwave Medical, Inc. Systems and methods for energy delivery
US11065188B2 (en) 2019-05-29 2021-07-20 Av Laboratories Llc Applications and formulations of optimized, modified human embryonic fertility culture media with biguanides and/or functional equivalents
AU2020286067A1 (en) * 2019-05-31 2022-01-06 Sumitomo Chemical Company, Limited Liquid suspension concentrate formulation comprising mefentrifluconazole
CN110721344B (zh) * 2019-11-21 2020-12-11 北京帝康医药投资管理有限公司 一种用于促进心肌修复的可注射生物凝胶及其制备方法
CN110898250B (zh) * 2019-11-28 2020-11-13 浙江大学 一种用于皮肤移植的自降解水凝胶粘合剂材料及其制备方法
US20210244846A1 (en) * 2020-02-07 2021-08-12 Nanyang Technological University Biofunctional hydrogel for wound healing
WO2021174008A1 (en) * 2020-02-28 2021-09-02 University Of Florida Research Foundation Compositions, methods, kits, and systems relating to charge-neutral microgels for 3d cell culture and printing
AU2021237731A1 (en) * 2020-03-20 2022-09-29 Bard Peripheral Vascular, Inc. Reactive hydrogel forming formulations and related methods
CN111840654B (zh) * 2020-08-04 2021-05-25 李双宏 一种改性透明质酸复合美容整形材料的制备方法
CN112370567B (zh) * 2020-11-19 2023-05-16 南方医科大学南方医院 一种具有抗菌消炎功能的水凝胶活性敷料
CN112708594B (zh) * 2021-01-26 2022-02-25 中科博生生物工程有限公司 脐带间充质干细胞复苏培养基及其制备方法和应用
CN113332499B (zh) * 2021-03-17 2022-06-28 上海玮沐医疗科技有限公司 一种自控温光热效应微球及其制备方法
KR20230130691A (ko) 2021-03-22 2023-09-12 선바이오(주) 폴리에틸렌 글리콜 유도체를 유효성분으로 포함하는구강건조증 완화용 구강린스 조성물
CN113341146B (zh) * 2021-04-29 2023-06-13 重庆医科大学 用于检测乙肝病毒的比色传感器及其制备与应用
CN113368216A (zh) * 2021-05-28 2021-09-10 薛安全 一种干眼症治疗制剂及其制备方法
IT202100017396A1 (it) * 2021-07-01 2023-01-01 Azienda Unita Sanitaria Locale Della Romagna Metodica di conservazione a temperatura ambiente di tessuti e organi destinati all’uso clinico
AU2022316212A1 (en) * 2021-07-21 2024-01-25 Organogenesis Inc. Porcine collagen compositions and methods of use thereof
CN115814157B (zh) * 2021-09-16 2024-06-07 齐鲁工业大学 一种用于骨整合材料的抗菌性涂层及其制备方法
CN114099776B (zh) * 2021-11-18 2022-09-30 南京工业大学 一种用于组织工程皮肤的颗粒凝胶复合支架及其制备方法
WO2023108124A1 (en) * 2021-12-09 2023-06-15 Likarda, LLC Hydrogel microparticle-based soft tissue fillers
WO2023122497A1 (en) * 2021-12-20 2023-06-29 University Of Florida Research Foundation, Inc. Microgels, methods of making microgels and methods of using microgels
CN114711326B (zh) * 2021-12-31 2023-09-22 上海食未生物科技有限公司 一种基于悬浮3d打印的食品打印材料、其制备方法和在人造肉中的应用
CN114276989A (zh) * 2021-12-31 2022-04-05 四川大学华西医院 递送脂肪干细胞的微凝胶及其制备方法
CN114307963A (zh) * 2022-01-12 2022-04-12 杭州星宇炭素环保科技有限公司 一种基于废旧棉织品的改性活性炭纤维及应用
CN114404672B (zh) * 2022-01-19 2023-03-03 四川大学 一种联合多酚和抗菌肽的纤维膜及其制备方法和应用
CN115282339B (zh) * 2022-07-28 2023-02-28 四川大学 一种交联透明质酸/羟基磷灰石可注射材料、制备方法及应用
WO2024030661A1 (en) * 2022-08-05 2024-02-08 University Of Washington Systems and methods for selective shape transformation of 3d-printed materials
CN115317665B (zh) * 2022-08-12 2023-08-18 济南格莱威医疗科技有限公司 一种聚酯粒子复合温敏即型凝胶皮下植入剂
CN115748249B (zh) * 2022-11-23 2024-06-25 浙江诸暨聚源生物技术有限公司 重组胶原蛋白水凝胶纤维及其制备方法
CN115845121A (zh) * 2022-12-07 2023-03-28 华南理工大学 止血、抗菌、促愈合的微凝胶组装体粉末及其制备方法
CN115607740B (zh) * 2022-12-21 2023-04-21 北京德益达美医疗科技有限公司 一种生长因子复合肌腱及其制备方法

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL128305C (pt) 1963-09-11
US4172066A (en) 1974-06-21 1979-10-23 The Dow Chemical Company Cross-linked, water-swellable polymer microgels
JPH0739508B2 (ja) * 1986-11-11 1995-05-01 株式会社林原生物化学研究所 プルラン・ポリエチレングリコ−ル会合物とその製造方法並びに用途
US5843156A (en) 1988-08-24 1998-12-01 Endoluminal Therapeutics, Inc. Local polymeric gel cellular therapy
JPH08502082A (ja) * 1992-07-02 1996-03-05 コラーゲン コーポレイション 生体適合性ポリマー結合体
EP0637450A3 (en) * 1993-08-04 1995-04-05 Collagen Corp Method and composition for resuscitation of hereditary tissue.
EP0705298B1 (en) 1993-12-01 2002-03-27 Bioartificial Gel Technologies Inc. Albumin based hydrogel
JPH10501706A (ja) * 1994-04-04 1998-02-17 コラーゲン コーポレイション 細胞−ゲル
US6129761A (en) 1995-06-07 2000-10-10 Reprogenesis, Inc. Injectable hydrogel compositions
US6150505A (en) 1997-09-19 2000-11-21 Hadasit Medical Research Services & Development Ltd. Fibrin microbeads prepared from fibrinogen, thrombin and factor XIII
US6818018B1 (en) * 1998-08-14 2004-11-16 Incept Llc In situ polymerizable hydrogels
US7582311B1 (en) 1999-10-15 2009-09-01 Genentech, Inc. Injection vehicle for polymer-based formulations
US7651703B2 (en) * 1999-10-15 2010-01-26 Genentech, Inc. Injection vehicle for polymer-based formulations
US6495164B1 (en) 2000-05-25 2002-12-17 Alkermes Controlled Therapeutics, Inc. I Preparation of injectable suspensions having improved injectability
US6552172B2 (en) 2001-08-30 2003-04-22 Habto Biotech, Inc. Fibrin nanoparticles and uses thereof
WO2003093433A2 (en) * 2002-05-02 2003-11-13 Regents Of The University Of Minnesota Fibrin-based biomatrix
CN100418619C (zh) 2003-01-17 2008-09-17 康乃尔研究基金会有限公司 可注射水凝胶微球和形成水凝胶微球的方法
AU2004237779B2 (en) 2003-04-30 2009-06-25 Drexel University Thermogelling polymer blends for biomaterial applications
EP1722834B1 (en) 2003-12-22 2012-06-27 Regentis Biomaterials Ltd. Matrix comprising naturally-occurring crosslinked protein backbone
CA2567532C (en) 2004-05-20 2013-10-01 Mentor Corporation Methods for making injectable polymer hydrogels
EP1891941A1 (en) * 2006-08-11 2008-02-27 OctoPlus Technologies B.V. Aqueous gels comprising microspheres
KR101512863B1 (ko) 2007-03-26 2015-04-16 백스터 인터내셔널 인코포레이티드 주입 가능한 연조직 증강용 공극 충전제
EP2150282B1 (en) 2007-04-16 2018-04-11 Regentis Biomaterials Ltd. Compositions and methods for scaffold formation
US20080268056A1 (en) 2007-04-26 2008-10-30 Abhijeet Joshi Injectable copolymer hydrogel useful for repairing vertebral compression fractures
US20110077737A1 (en) 2007-07-30 2011-03-31 Allergan, Inc. Tunably Crosslinked Polysaccharide Compositions
US9987221B2 (en) 2007-08-23 2018-06-05 Boston Scientific Scimed, Inc. Injectable hydrogel compositions
US7993679B2 (en) 2007-09-25 2011-08-09 Integra Lifesciences Corporation Flowable wound matrix and its preparation and use
WO2009079555A2 (en) 2007-12-17 2009-06-25 Anna Love Soft tissue filler
US20090202642A1 (en) * 2008-02-08 2009-08-13 Xiao Huang Drug Delivery System Comprising Microparticles and Gelation System
JP5574083B2 (ja) 2008-08-01 2014-08-20 アンタイス エス．エイ． 高い残留性及び容量を与える高い能力を有する注入可能なヒドロゲル
US8557288B2 (en) 2008-08-15 2013-10-15 Washington University Hydrogel microparticle formation in aqueous solvent for biomedical applications
CN101721349B (zh) 2008-10-16 2011-07-20 常州百瑞吉生物医药有限公司 可注射原位交联水凝胶及其制备方法和用途
IL195764A0 (en) 2008-12-07 2009-11-18 Technion Res & Dev Foundation Compositions and methods for drug delivery
WO2011005381A2 (en) * 2009-06-01 2011-01-13 Trustees Of Tufts College Vortex-induced silk fibroin gelation for encapsulation and delivery
CA2784847C (en) 2009-12-18 2017-11-21 Molly Sandra Shoichet Injectable polymer composition for use as a cell delivery vehicle
WO2012002986A2 (en) 2009-12-21 2012-01-05 The Regents Of The University Of California Decellularized and delipidized extracellular matrix and methods of use
JP2015508104A (ja) * 2012-02-22 2015-03-16 トラスティーズ オブ タフツ カレッジ 治療薬の眼への送達のための組成物および方法
US20140170224A1 (en) * 2012-12-14 2014-06-19 Agency For Science, Technology And Research Gelatin-based microgels
US20140227364A1 (en) 2013-02-08 2014-08-14 Kimberly A. Kentner Methods of manufacturing bioactive gels from extracellular matrix material

Also Published As

Publication number Publication date
CN107708675B (zh) 2022-07-22
US20160303281A1 (en) 2016-10-20
DK3283057T3 (da) 2021-11-01
BR112017022045B1 (pt) 2023-11-28
WO2016168196A1 (en) 2016-10-20
CA2982352A1 (en) 2016-10-20
EP3283057B1 (en) 2021-07-28
PT3283057T (pt) 2021-11-04
EP3283057A1 (en) 2018-02-21
CN107708675A (zh) 2018-02-16
ES2895947T3 (es) 2022-02-23
EP3283057A4 (en) 2018-12-12
US20210308323A1 (en) 2021-10-07
KR102592242B1 (ko) 2023-10-25
MX2017013002A (es) 2018-02-01
JP6930733B2 (ja) 2021-09-01
AU2016250012A1 (en) 2017-11-02
AU2016250012B2 (en) 2020-12-03
US11590259B2 (en) 2023-02-28
JP2018511622A (ja) 2018-04-26
HK1245663A1 (zh) 2018-08-31
KR20170140274A (ko) 2017-12-20

Similar Documents

Publication Publication Date Title
BR112017022045A2 (pt) composição e kits para matrizes de microgel pseudoplástico
BR112018008625A2 (pt) ?processos para preparar um produto de carbono poroso conformado e uma composição catalisadora, produto de carbono poroso conformado, e, composição catalisadora?
BR112017012851A2 (pt) sistemas de modificação de genoma fúngico e métodos de uso
BR112018005937A2 (pt) conjugados de oligonucleotídeo de afinidade e usos destes
EP4257596A3 (en) Coumarin compounds and their uses as fluorescent labels
BR112015023398A8 (pt) Métodos para amplificar ácidos nucléicos
BR112017014230A2 (pt) endófitos de semente através de cultivares e espécies, composições associadas e métodos de uso dos mesmos
BR112018007070A2 (pt) método, composição e kit para a preparação de uma planta a partir de um protoplasto, planta regenerada e composição para clivagem de dna
BR112018004108A2 (pt) ochrobactrum haywardense h1 isolada, ochrobactrum haywardense h1, método para produzir uma célula vegetal transformada, kit e vetor
BR112017012482A2 (pt) copolímero estático, composição, uso de um copolímero, e, métodos para liberar um ácido nucleico a uma célula ou tecido alvo e para a produção do copolímero.
BR102014027438A8 (pt) Sequência recombinante, uso de uma planta, de uma parte de planta, ou de uma célula de planta de milho, método para preparação de uma célula vegetal transgênica, e sequências recombinante e genômica de milho
BR112016022814A8 (pt) composição farmacêutica e seu método de preparação, ácido nucleico, e dispositivo médico ou kit médico
MX2020003841A (es) Métodos y composiciones para la producción de nucleósido trifosfatos y ácidos ribonucleicos.
EA201600044A1 (ru) Композиции для интродукции рнк в клетки
BR112017013691A2 (pt) composição compreendendo um polímero em multiestágio, seu método de preparação e seu uso
BR112017006533A2 (pt) usos de trealose em suspensões celulares
BR112017006302A2 (pt) composição de circulação perdida, método para obstruir uma zona de circulação perdida e sistema para obstruir uma zona de circulação perdida
BR112012019396A2 (pt) método e kit para amplificar um ácido nucleico.
BR112016015105A2 (pt) Conjugados var2csa-droga
BR112018071221A2 (pt) composições e métodos para programar células terapêuticas usando nanocarreadores de ácido nucleico alvejados
BR112017016897A2 (pt) cepas fúngicas e métodos de uso
BR112016026136A2 (pt) composições e métodos para aumentar o desenvolvimento e o rendimento vegetal
BR112015021708A2 (pt) Inibidor de polipetídeo do tnfa, polinucleotídeo isolado, estrutura de expressão de ácido nucleico, célula de planta, composição farmacêutica e método de produção de um inibidor de polipeptídeo do tnfa
BR112018014026A2 (pt) composição líquida compreendendo um polímero múltiplas fases, seu método de preparação e uso
BR112016029207A2 (pt) resinas de polietileno

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 12/04/2016, OBSERVADAS AS CONDICOES LEGAIS